Browse > Article

Screening of the Biologoical Activity from Water Extracts of the Medicinal Plants and the Protective Effect of R. palmatum on MTPT-induced Neurotoxicity  

Kim Tae Eun (Department of Physiology, College of Oriental Medicine, Sangji University)
Yoon Yeo Min (Department of Physiology, College of Oriental Medicine, Sangji University)
Park Yong In (Department of Physiology, College of Oriental Medicine, Sangji University)
Kim Youn Seok (Department of Rehabilitation, Joong Hwa Oriental Medical Hospital)
Jeon Byung Hun (Department of Pathology, College of Oriental medicine, Wonkwang University)
Kim Myung Dong (Department of Physiology, College of Oriental Medicine, Sangji University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.18, no.6, 2004 , pp. 1666-1685 More about this Journal
Abstract
This present study was designed to screen medicinal plants for the treatment of brain diseases such as Parkinson's disease or aging. We tested the effects of the water extracts from 38 species medicinal plants on antioxidant capacity, monoamine oxidase B (MAO-B) inhibitory activity, acetylcholinesterase (AChE) inhibition and antiperoxidation activity in vitro. The water extracts from 38 species were tested on their antioxidant activity using radical scavenging effects against ABTS+. The water extract of C. sappan was showed the highest antioxidant capacity, the antioxidant activity at 1 Jig of herbal extract being 0.38mM TE. Lipid peroxidation in brain homogenates induced by NADPH and ADP-Fe/sup 2+/ was strong inhibited by C. sappan and R. palmatum extracts. Among the 38 medicinal plants investigated, R. palmatum showed significant biological activity (antioxidant capacity, MAO-B inhibiory activity, and AChE inhibitory activity). The protective efficacy of R. palmatum water extract on 1-methyl-4­phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism and its possible mechanism were studied in C57BL/6 mice. Treatment of R. palmatum water extract protected biomacromolecules such as lipids from oxidative damage induced by MPTP. The content of MDA in brain tissue was decreased significantly by R. palmatum extract. These results suggest that R. palmatum water extract plays on effective role in attenuating MPTP-induced neurotoxicity in mice. This protective effect of R. palmatum might be estimated the result from the inhibitory activity on monoamine oxidase B and the enhancement of antioxidant activity.
Keywords
Parkinson's disease; R. palmatum; C. sappan; Antioxidant Activity; Acetylcholinesterase Inhibitor; Monoamine Oxidase B Inhibitor;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Role of free radicals and catalytic metal ions in human disease: an overview /
[ Halliwell, B.;Gutteridge, J.M.C. ] / Methods in Enzymology
2 Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridinium, a metabolite of the neurotoxine, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine /
[ Nicklas, W.J.;Vyas, I.;Heilkkila, R.E. ] / Life Sci.
3 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine is neurotoxic to the nigro-striatal dopamine pathway /
[ Bradbury, A.J.;Costall, B.;Domeney, A.M.;Jenner, P.;Kelly, M.E.;Marsden, C.D.;Naylor, R.J. ] / Nature
4 /
[ 袁立人 ] / 中醫老年病學
5 Oat antioxidants /
[ Peterson, D.M. ] / Journal of Cereal Science
6 Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion /
[ Mizumo, Y.;Saitoh, T.;Sone, N. ] / Biochem. Biophys. Res. Comm.
7 Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity /
[ Irwin, I.;Langston, J.W. ] / Life Sci.
8 Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: relationship with low levels of regional monoamine oxidase-B /
[ Mitra, M.;Mohanakumar, K.P.;Ganguly, D.K. ] / J. Neurochem.
9 Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases /
[ Alexi, T.;Borlongan, C.V.;Faull, R.L.M.;Williams, C.E.;Clark, R.G.;Gluckman, P.D.;Hughes, P.E. ] / Progress in Neurobiology
10 Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridinium ion /
[ Mytilineou, C.;Cohen, G. ] / J. Neurochem.
11 Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals /
[ Kopin, I.J. ] / Adv. Neurol.
12 Protection against the dopaminergic neurotoxicity of 1- methyl- 4- phenyl- 1,2,5,6 -tetrahydropyridine by monoamine oxidase inhibitor /
[ Heikkila R.E.;Manzino, L.;Cabbat, F.S.;Duvoisin, R.C. ] / Nature
13 Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, A nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine /
[ Sabline, S.O.;Krueger, M.J.;Bachurin, S.O.;Solyakov, L.S.;Efange, S.M.N.;Singer, T.P. ] / J. Neurochem.
14 The specific vulmerability of the substantia nigra to MPTP is related to the presence of transition metals /
[ Poirier, J.;Donaldson, J.;Barbeau, A. ] / Biochem. Biophys. Res. Commun.
15 Apomorphine protects against MPTP-induced neurotoxicity in mice /
[ Grunblatt, E.;Mandel, S.;Berkuzki, T.;Youdim, M.B.H. ] / Movement Disorders
16 Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys /
[ Cohen, G.;Pasik, P.;Cohen, B.;Leist, A.;Mytilineous, C.;Yahr, M.D. ] / Eur. J. Pharmacol.
17 Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium /
[ Koutsilieri, E.;Chen, T.S.;Rausch, W.D.;Riederer, P. ] / Eur. J. Pharmacol.
18 (-)-deprenyl of 1-methyl-4-phenylpyridinium ion (MPP+) -induced apotosis independent of MAO-B inhibition /
[ Le, W.;Jankovic, J.;Xie, W.;Kong, R.;Appel, S.H. ] / Neurosci. Letters
19 The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons /
[ Rothblat, D.S.;Schneier, J.S. ] / Brain Res.
20 7-Nitroindazole prevents 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine induced ATP loss in the mouse striatum /
[ Royland, J.E.;Delfani, K.;Langston, J.W.;Janson, A.M.;Monte, D.A. ] / Brain Res.
21 MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders? /
[ Foley, P.;Gerlach, M.;Youdim M.B.H.;Rieder, P. ] / Parkinsonism Related Disorders
22 The protective of riluzole in the MPTP model of Parkinson's disease in mice is not due to in MPP+ accumulation /
[ Boireau, A.;Dubedat, P.;Bordier, F.;Imperato, A.;Moussaou, S. ] / Neuropharmacol.
23 Brief communication azulenyl nitrone spin trap protect against MPTP neurotoxicity /
[ Klivenyi, P.;Matthews, R.;Wermer, M.;Yang, L.;MacGarvey, U. Becker, D.;Natero, R.;Beal, M.F. ] / Exp. Neurol.
24 Biological effects of the superoxide radical /
[ Fridovich, I. ] / Arch. Biochem. Biophys.
25 Historical introduction to free radical and antioxidant biomedical research /
[ Miquel, J.;Miquel, J.;Quintanilha, A.T.;Weber, H.(Eds.) ] / CRC handbook of free radical and antioxidants in biomedicine
26 Oxidative processes and antioxidative defense mechanism in the aging brain /
[ Reiter, R.J. ] / FASEB J.
27 Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice /
[ Wu, W.R.;Zhu, X.Z. ] / Life Sci.
28 Neuroprotection by sodium salicylate against 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity /
[ Mohankumar, K.P.;Muralikrishnan, D.;Thomas, B. ] / Brain Res.
29 Monoamine oxidase_B inhibitors in treatment Alzheimers disease /
[ Thomas, T. ] / Neuro. Aging
30 Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in C57BL/6 mice /
[ Zou, L.L.;Xu, J.;Jankovic, J.;He, Y. Appel, S.H.;Le, W.D. ] / Neurosci. Lettters
31 Elevation of antioxidant potency in the brain of mice by low-dose <TEX>$\gamma$</TEX>-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced brain damage /
[ Kojima, S.;Matsuki, O.;Nomura, T.;Yamaoka, K.;Takahashi, M.;Niki, E. ] / Free Rad. Biol. Med.   ScienceOn
32 /
[ 方藥中(主編) ] / 實用中醫內科學
33 /
[ 공廷賢 ] / 增補 萬病回春
34 /
[ 謝觀 ] / 東洋醫學大辭典
35 /
[ 李천 ] / 編註 醫學入門(全五卷中二)
36 Serum lipoperoxide levels in patients suffering from liver disease /
[ Suematsu, T.;Kamada, T.;Abe, H.;Kikuchi, S.;Yagi, K. ] / Clin. Chem. Acta.
37 /
[ 孫思邈 ] / 備急千金要方(卷四十)
38 /
[ 金昌玟;辛民敎;安德均;李京淳 ] / 中藥大辭典
39 Total antioxidant status in plasma and body fluids /
[ Rice-Evans, C.;Miller, N.J. ] / Methods Enzymol.
40 Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood brain barrier monoamine oxidase activity /
[ Kalaria, R.N.;Mitchell, M.J.;Harik, S.I. ] / Proc. Natl. Acad. Sci. USA.
41 A new and rapid colorimetric determination acetylcholinesterase activity /
[ Ellman, G.L.;Coutney, K.D.;Andres, V. Jr.;Featherstone, R.M. ] / Biochem. Pharmacol.
42 The contribution of plant food antioxidants to human health /
[ Ramarathnam, N.;Osawa, T.;Ochi, H.;Kawakishi, S. ] / Food Sci. Technol. International
43 三和散이 腦組織의 acetylcholine esterase 및 monoamine oxidase 活性에 미치는 影響 /
[ 徐榮浚;申鉉喆;尹哲浩;鄭智天;申億變 ] / 韓方成人病學會誌
44 七福飮이 노화 백서 뇌조직의 생화학적 변화에 미치는 영향 /
[ 손정석;류영수 ] / 東醫神經精神科學會誌
45 定志丸이 腦組織의 生化學的 變化와 神經細胞의 損傷에 미치는 實驗的 硏究 /
[ 崔龍埈;成彊慶;文炳淳 ] / 大韓韓醫學會誌
46 Monoamine oxidase activity and monoamine metabolism in brains of Parkinsonianpatients treated with L-deprenyl /
[ Riederer, P.;Youdim, M.B.H. ] / J. Neurochem.
47 Relationship of resistance to oxygen free radicals to CuZn-superoxide dismutase activity in trasgenic, transfected, and trisomic cells /
[ Huang, T.T.;Carlson, E.J.;Leadon, S.A.;Epstein, C.J. ] / FASEB J.
48 Protein measurment with the Folin-phenol reagent /
[ Lowry, O.H.;Rosebrough, H.J.;Farr, A.L.;Randall, R.J. ] / J. Biol. Chem.
49 Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and glutathione system /
[ Benzi, G.;Moretti, A. ] / Free Rad. Biol. Med.
50 Are reative oxygen species involved in Alzheimer's disease? /
[ Benzi, G.;Moretti, A. ] / Neurobiol. Aging
51 Screening of the acetylcholinesterase inhibitors from medicinal plants /
[ Lee, B.H.;Choi, B.W.;Ryu, G.S.;Lee, E.S.;Kang, K.J.;Hwang, D.Y.;Hong, N.D. ] / Kor. J. Pharmacogn.
52 Kinetic evaluation of MAO-B activity following oral administration of selegiline and desmethyl-selegiline in the rat /
[ Borbe, H.O.;Niebch, G.;Nickel, B. ] / J. Neural. Transm.
53 Pargyline-induced mania in primary affective disorder: case report /
[ Folks, D.;Arnold, E.S. ] / J. Clin. Psychiatry
54 Comparative antioxidant potential of anaethetics and perioperative drugs in vitro /
[ Mantle, D.;Eddeb, F.;Areni, K.;Snowden, C.;Mendelow, A.D. ] / Clinica Chimica Acta
55 Shortcomings of an automated assay for total antioxidant status in biological fluids /
[ Schofield, D.;Braganza, J.M. ] / Clin Chem
56 Analytical aspects of antioxidants and free radical activity in clinical biochemistry /
[ Rumley, A.G.;Patterson, J.R. ] / Ann. Clinical Biochem.
57 Is measuring serum antioxidant capacity clinically useful? /
[ Woodford, F.P.;Whitehead, T.P. ] / Annals of Clinical Biochemistry
58 Comparison of relative antioxidant activities of British medicinal plant species in vitro /
[ Mantle, D.;Eddeb, F.;Pickering, A.T. ] / J. Ethnopharmacol.
59 Hydroxyl radical scavenging activity of flavonoids /
[ Husain, S.R.;Cillard, J.;Cillard, P. ] / Phytochem.
60 Age- related changes in reactive oxygen species production in rat brain homogenates /
[ Driver, A.S.;Kodavanti, P.R.S.;Mundy, W.R. ] / Neurotoxicol. Teratology
61 Effective human cancer prevention as goal for the regulation of environmental chemicals /
[ Weisburger, J.H. ] / J. Environ. Health
62 No changes in behavior, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats /
[ Widdowson, P.S.;Farnworth, M.J.;Upton, R.;Simpson, M.G. ] / Human Exp. Toxicol.
63 Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo /
[ Ferger, B.;Spratt, C.;Earl, C.D.;Teismann, P.;Oertel, W.H.;Kuschinsky, K. ] / Naunyn. Schmiedebergs. Arch. Pharmacol.
64 Mechanism of food restriction: Protection of cellular homeostasis /
[ Yu, B.P.;Lee, D.W.;Marler, C.G.;Choi, J.H. ] / Proc. Soc. Exp. Biol. Med.
65 MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways /
[ Hung, H.C.;Lee, E.H.Y. ] / Free Rad. Biol. Med.
66 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake /
[ Johnson, E.A.;Wu, E.Y.;Rollema, H.;Booth, R.G.;Trevor, A.J.;Castagnoll, N. ] / Eur. J. Pharmacol.
67 /
[ Paykel, E.S.;Rowan, P.R.;Rao, B.M.;Bhat, A.;Cayton, P.J.;Barnett, J.E.(Eds.) ] / Treatment of Depression, Old Controversis and New Approaches
68 The neurotoxicity and the relevance to Parkonson's disease /
[ Mccrodden, J.M.;Tipton, K.F.;Sullivan, J.P. ] / Pharm. Toxicol.
69 Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4- phenyl-1,2,3,6- tetrahydropyridinyl derivatives /
[ Inoue, H.;Castagnoli, K.;van der Schyf, C.;Mabic, S.;Igarashi, K.;Castagnoli, N.Jr. ] / J. Pharmacol. Exp. Ther.
70 /
[ Birkmayer, W.;Riederer, P.;Rausch, W.D.;Poirier, L.H.;Sourkes, T.L.;Bedard, J.P.(Eds.) ] / In advances in neurology
71 The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection /
[ Cross, A.J.;Joseph, M.H. ] / Life Sci.
72 Quinoline and quinaldine as naturally occurring inhibitors specific for type A monoamine oxidase /
[ Naoi, M.;Nagatsu, T. ] / Life Sci.
73 Screening of unsubstituted cyclic compounds as inhibitors of monoamine oxidases /
[ Thull, U.;Testa, B. ] / Biochem. Pharmacol.
74 Isolation of monoamine oxidase B inhibitory compound from the leaves of Eucommia ulmoides /
[ Baek, N.-I.;Ahn, E.-M.;Hahn, J.-T.;Lee, D.W.;Sohn, H.O.;Kwon, B.-M. ] / J. Kor. Soc. Agric. Chem. Biotechnol.
75 Phenolics with inhibitory activity on mouse brain monoamine oxidase (MAO) from whole parts of Artemisia vulgaris L (Mugwort) /
[ Lee, S.-J.;Chung, H.-Y.;Lee, I.-K.;Oh, S.-U.;Yoo, I.-D. ] / Food Sci. Biotechnol.
76 Difference in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/BL and CD-1 mice /
[ Muthane, U.;Ramsay, K.A.;Jiang, H.;Jackson-Lewis, V.;Donaldson, D.;Fernando, S.;Ferreira, M.;Prezedborski, S. ] / Exp. Neurology
77 Spontaneaus blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys /
[ Taylor, J.R.;Elsworth, J.D.;Lawrence, M.S.;Sladek, J.R.;Roth, R.H.;Redmond, D.E. ] / Exp. Neurology
78 Comparative toxicity of MPTP, MPP+ and 3,3- dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra /
[ Sayre, L.M.;Arora, P.K.;Iacofano, L.A.;Harik, S.I. ] / Eur. J. Pharmocol.
79 MK-81 fail to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridium in rats /
[ Sonsalla, P.K.;Zeevalk, G.D.;Manzino, L.;Giovanni, A.;Nicklas, W.J. ] / J. Neurochem.
80 Prevalence of Alzheimer' disease in community population of older persons /
[ Evans, D.A.;Funkenstein, H.H.;Altert, M.S.;Scherr, P.A.;Cook, N.R.;Chown, M.J.;Herbert, L.E.;Hennekens, C.H.;Taylor, J.O. ] / JAMA
81 /
[ National Institute on Aging ] / Progress Report on Alzheimer's disease (NIH Publication 95-3994)
82 Diagnosis of Alzheimer's disease /
[ Khachaturian, Z.S. ] / Arch. Neurol.
83 Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene /
[ Branen, A.L. ] / J. Am. Oil Chem. Soc.
84 NADPH-dependent and O2-dependent lipid-peroxidation /
[ Nizamuddin, A. ] / Biochem. Pharmacol.
85 A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish /
[ Takao, T.;Kitatani, F.;Watanabe, N.;Yagi, A.;Sakata, K. ] / Biosci. Biotechnol. Biochem.
86 Oxidative stress and genetics in the pathogenesis of Parkinsons disease /
[ Zhang, Y.;Dawson, V.L.;Dawson, T.M. ] / Neurobiol. Disease
87 Phenolic antioxidants: health protection branch studies on butylated hydroxyanisole /
[ Iverson, F. ] / Cancer Letters
88 Evidence fro neuronal oxidative damage in Alzheimer's disease /
[ Good, P.F.;Werner, P.;Hsu, A.;Olanow, C.W.;Perl, D.P. ] / Am. J. Pathol.
89 Acetylcholinesterase in Alzheimer's disease /
[ Talesa, V.N. ] / Mechanism Aging Develop.
90 Possible causes of Alzheimer's disease: Amyloid fragments, free radicals, and calcium homeostasis /
[ Holscher, C. ] / Neurobiol. Disease
91 Neurotransmitters and C.N.S. disease dementia /
[ Rossor, M.N. ] / Lancet
92 Cognitive enhancement therapy for Alzheimer's disease The way forward /
[ Parnetti, L.;Senin, U.;Mecocci, P. ] / Drug
93 Acetylcholinesterase inhibition by territrem B derivatives /
[ Peng, F.C. ] / J. Nat. Pro.
94 The prevalence of dementia: A quantitative integration of the literature /
[ Jorm, A.;Korten, A.;Henderson, A. ] / Acta Psychiat. Scand.
95 Neuroprotective therapy for Parkinson's disease. /
[ Koller, W.C. ] / Exp. Neurol.
96 Metal ion-catalyzed oxidation of proteins: biochemical mechanisms and biological consequences /
[ Stadtman, E.R. ] / Free Radic. Biol. Med.
97 Oxy-radicals and cancer /
[ Cerutti, P.A. ] / Lancet
98 Oxidative stress: free radical production in neural degeneration /
[ Gotz, M.E.;Kunig, G.;Riederer, P.;Youdim, M.B. ] / Pharmacol. Therapeutics
99 Oxidative damage to DNA in diabetes mellitus /
[ Dandona, P.;Thusu, K.;Cook, S.;Snyder, B.;Makowski, J.;Armstrong, D.;Nicotera, T. ] / Lancet
100 Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia /
[ O'Neill, M.;Hicks, C.;Ward, M.;Panetta, J.A. ] / Brain Res.
101 Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects /
[ Handy, R.L.C.;Harb, H.L.;Wallace, P.;Gaffen, Z.;Whitehead, K.J.;Moore, P.K. ] / Br. J. Pharmacol.
102 Qualitative and quantitative evaluation of anthraquinone derivaties in Indian rhubarb /
[ Shah, C.S.;Qadry, J.S.;Bhatt, J.G. ] / Planta Med.
103 Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study /
[ Jossan, S.S.;Gillberg, P.G.;Gottfries, C.G.;Karlsson, I.;Oreland, L. ] / Neuro. Sci.
104 The molecular pharmacology of L-deprenyl /
[ Gerlach, M.;Richardson, P.;Youdim, M.B.H. ] / Eur. Pharmacol. Mol. Pharmacol. Sect.
105 Purification and properties of human brain mitochondrial monoamine oxidase /
[ Nagatsu, T.;Yamamoto, T.;Harada, M. ] / Enzymologia
106 Pharmacological treatment of cognitive deficits in Azheimer's disease /
[ Brodaty, H.;Ames, D.;Boundy, K.L.;Hecker, J.;Snowdon, J.;Storey, E.;Yates, M.W. ] / Med. J. Aust.
107 Alzheimer's disease: lesions and their progression /
[ Duyckaerts, C.;Colle, M.A.;Delatour, B.;Hauw, J.J. ] / Rev. Neurol.
108 Cholinesterase in cerebrosponal fluid. A longitudinal study in Alzheimer disease /
[ Elble, R.;Giavobini, E.;Scarsella, G.F. ] / Arch. Neurol.
109 Alzheimer's disease; A disorder of cortical cholinergic innervation /
[ Coyel, J.T.;Price, D.L.;Long, M.R. ] / Science
110 MPTP mechanism of neurotoxicity and their implications for Parkinson's disease /
[ Gerlach, M.;Riederer, P.;Przuntex, H.;Youdim, M.B.H. ] / Eur. Pharmac. Mol. Pharmacol. Sect.
111 Chronic parkinsonism in human due to a product of meperidine analog synthesis /
[ Langstone, J.W.;Ballard, P.;Irwin, R.A. ] / Science
112 The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in the monkey and man /
[ Burns, R.S.;Markey, S.P.;Phillips, J.M.;Chiueh, C.C. ] / Can. J. Neurol. Sci.
113 Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase /
[ Chiba, K.;Trevor, A.;Castagnoli, N.J. ] / Biochem. Biophys. Res. Commun.
114 An acetylcholinesterase inhibitor isolated from Corydalis Tuber and its mode of action /
[ Hwang, S.Y.;Chang, Y.P.;Byun, S.J.;Jeon, M.H.;Kim, Y.C. ] / Kor. J. Pharmacogn.
115 Intraneuronal generation of a pyridinium metabolic may cause drug-induced parkinsonism /
[ Markey, S.P.;Johannesse, J.N.;Chiueh, C.S.;Herkenham, M.A. ] / Nature
116 Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice /
[ Sriram, K.;Pai, K.S.;Boyd, M.R.;Ravindranath, V. ] / Brain Res.
117 /
[ Adams, J.D.;Johannessen, J.H.M.;Schuller, J.P.;Bacon, S.P.;Markey, S.P. ] / The role of oxidative stress in the systematic toxicity of MPTP and MPP+
118 MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes /
[ Adams, J.D.;Klaidman, L.K.;Leung, A.C. ] / Free Radic. Biol. Med.
119 MPTP-induced oxidative stress and neurotoxicity are age-dependent: evidence from measures of reactive oxygen species dopamine levels /
[ Ali, S.F.;David, S.N.;Newport, G.D.;Cadet, J.L.;Slikker, W.J. ] / Synapse
120 Oxidative stress induced by MPTP and MPP+: selective vulnerability of cultured astrocytes /
[ Wong, S.S.;Li, R.H.Y.;Stadlin, A. ] / Brain Res.
121 Substrate and inhibitor- related characteristics of human platelet monoamine oxidase /
[ Donnelly, C.H.;Murphy, D.L. ] / Biochem. Pharmacol.
122 The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines /
[ Yang, H.Y.T.;Neff, N.H. ] / J. Pharm. Exp. Ther.
123 Effect of MPTP and L-Deprenyl on antioxidants enzymes and lipid peroxidation level in mouse brain /
[ Thiffault, C.;Aumont, N.;Quirion, R.;Poirier, J. ] / J. Neuro. Int. Soc. Neurochem.
124 Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain /
[ Chan, P.;Delanney, L.E.;Irwin, I.;Langston, J.W.;Monte, D.D. ] / J. Neurochem.
125 Inhibition of mitochondrial NADH dehydrogenase by pyridine derivaties and its possible relation to experimental and idophathic Parkinsonism /
[ Ramsay, R.R.;Salach, J.I.;Dadgar, J.;Singer, T.P. ] / Biochem. Biophys. Res. Commun.
126 Organic hydroperoxide-induced lipid peroxidation and cell death in isolated hepatocytes /
[ Rush, G.F.;Gorski, J.R.;Ripple, M.G.;Sowinski, J.;Bugelski, P.;Hewitt, W.R. ] / Toxicology and Applied Pharmacology